"Drugs, Generic" is a descriptor in the National Library of Medicine's controlled vocabulary thesaurus,
MeSH (Medical Subject Headings). Descriptors are arranged in a hierarchical structure,
which enables searching at various levels of specificity.
Drugs whose drug name is not protected by a trademark. They may be manufactured by several companies.
Descriptor ID |
D016568
|
MeSH Number(s) |
D26.360
|
Concept/Terms |
Drugs, Generic- Drugs, Generic
- Drugs, Nonproprietary
- Nonproprietary Drugs
- Generic Drugs
|
Below are MeSH descriptors whose meaning is more general than "Drugs, Generic".
Below are MeSH descriptors whose meaning is more specific than "Drugs, Generic".
This graph shows the total number of publications written about "Drugs, Generic" by people in this website by year, and whether "Drugs, Generic" was a major or minor topic of these publications.
To see the data from this visualization as text,
click here.
Year | Major Topic | Minor Topic | Total |
---|
2006 | 1 | 0 | 1 |
2011 | 2 | 1 | 3 |
2012 | 1 | 1 | 2 |
2014 | 2 | 0 | 2 |
2017 | 21 | 5 | 26 |
2018 | 12 | 9 | 21 |
2019 | 5 | 6 | 11 |
2020 | 0 | 1 | 1 |
2021 | 0 | 2 | 2 |
To return to the timeline, click here.
Below are the most recent publications written about "Drugs, Generic" by people in Profiles.
-
Development and validation of a predictive model to predict and manage drug shortages. Am J Health Syst Pharm. 2021 07 09; 78(14):1309-1316.
-
National trends in prescription drug expenditures and projections for 2021. Am J Health Syst Pharm. 2021 07 09; 78(14):1294-1308.
-
Evidence-based public policy making for medicines across countries: findings and implications for the future. J Comp Eff Res. 2021 08; 10(12):1019-1052.
-
Pool patents to get COVID vaccines and drugs to all. Nature. 2021 03; 591(7851):529.
-
A Non-Profit Approach to Address Foreign Dependence of Generic Drugs. J Law Med Ethics. 2021; 49(1):30-33.
-
COVID-19, host response treatment, and the need for political leadership. J Public Health Policy. 2021 Mar; 42(1):6-14.
-
Transferrable Market Exclusivity Extensions to Promote Antibiotic Development: An Economic Analysis. Clin Infect Dis. 2020 10 23; 71(7):1671-1675.
-
[The sustainability of the health system and the pharmaceutical market: A permanent interaction between the cost of medications, the patent system, and disease care]. Salud Colect. 2020 10 17; 16:e2897.
-
Were it business opportunities or hidden risks: Observations on clinical trials and marketing authorizations of Gilead Science's remdesivir in China. Pharmazie. 2020 08 01; 75(8):407-410.
-
The case for compulsory licensing during COVID-19. J Glob Health. 2020 Jun; 10(1):010358.